HBMEC‐derived EVs induce translocation of S100A16 from the cytoplasm to the nucleus in the recipient cells, which triggers the expression of prohibitin‐1, facilitating apoptosis‐resistance in metastatic lung cancer cells in the brain (Xu et al., 2019). Here, S100A16 is linked to lung cancer.